MedPath

Changchun Zhuoyi Biological Co., Ltd.

Changchun Zhuoyi Biological Co., Ltd. logo
🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 3:2
Phase 4:1

Drug Approvals

2

PHILIPPINES:2

Drug Approvals

JoyRab

Approval Date
Jul 14, 2025
PHILIPPINES

Bioshoot

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (66.7%)
Phase 4
1 (33.3%)

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

Phase 3
Completed
Conditions
Antibody Titer
Rabies Human
First Posted Date
2022-09-22
Last Posted Date
2024-03-13
Lead Sponsor
Changchun Zhuoyi Biological Co., Ltd
Target Recruit Count
1800
Registration Number
NCT05549908
Locations
🇨🇳

Changchun Zhuoyi Biological Co., Ltd, Changchun, Jilin, China

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

Phase 4
Completed
Conditions
Antibody
Rabies
First Posted Date
2022-09-21
Last Posted Date
2022-09-21
Lead Sponsor
Changchun Zhuoyi Biological Co., Ltd
Target Recruit Count
149
Registration Number
NCT05547815
Locations
🇨🇳

Changchun Zhuoyi Biological Co., Ltd, Changchun, Jilin, China

Prevention of Rabies With Four Doses of Rabies Vaccine

Phase 3
Conditions
Antibody
Rabies Human
First Posted Date
2022-09-19
Last Posted Date
2024-07-10
Lead Sponsor
Changchun Zhuoyi Biological Co., Ltd
Target Recruit Count
2100
Registration Number
NCT05545371
Locations
🇨🇳

Changchun Zhuoyi Biological Co., Ltd, Changchun, Jilin, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.